Intellia Therapeutics
NTLA
#4597
Rank
A$2.58 B
Marketcap
$25.41
Share price
4.56%
Change (1 day)
-35.25%
Change (1 year)

Earnings for Intellia Therapeutics (NTLA)

Earnings in 2024 (TTM): -A$0.77 Billion

According to Intellia Therapeutics's latest financial reports the company's current earnings are A$45.96 Million. In 2023 the company made an earning of -A$0.74 Billion a decrease over its 2022 earnings that were of -A$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intellia Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.77 Billion5.18%
2023 -A$0.74 Billion1.48%
2022 -A$0.73 Billion77.01%
2021 -A$0.41 Billion99.58%
2020 -A$0.21 Billion34.86%
2019 -A$0.16 Billion16.63%
2018 -A$0.13 Billion26.35%
2017 -A$0.11 Billion113.51%
2016 -A$48.04 Million135.92%
2015 -A$20.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.2 Billion-75.41%๐Ÿ‡บ๐Ÿ‡ธ USA